文献速递静脉血栓栓塞外周动脉疾病颈动脉与弓上血管

COVID-19患者入院时血栓形成特征分析

Thrombosis at hospital presentation in patients with and without coronavirus disease 2019.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-11-10

单中心回顾性分析比较了COVID-19与非COVID-19患者入院时诊断的动脉或静脉血栓形成。2020年与2019年相比,静脉血栓栓塞占比从29.4%升至52.7%,心肌梗死和卒中占比下降。

要点

  • COVID-19相关血栓患者入院时静脉血栓栓塞占比升高至52.7%。
  • COVID-19相关血栓患者更年轻但死亡率更高(15.2% vs 4.3%)。
  • 炎症标志物显著升高提示免疫血栓形成机制可能参与。

核心结论

  • COVID-19门诊患者因血栓形成需住院者死亡率高于非COVID-19血栓住院患者。
  • 炎症标志物显著升高提示COVID-19相关血栓机制可能不同,炎症或为治疗靶点。

研究设计与样本

  • 单中心回顾性分析COVID-19患者,比较2019年与2020年血栓亚型比例变化。

主要发现

  • 2019至2020年,ST段抬高型心肌梗死占血栓事件比例从22.0%降至10.1%,卒中从48.6%降至37.2%,静脉血栓栓塞从29.4%升至52.7%。
  • COVID-19相关血栓患者全血细胞计数、肝功能、D-二聚体、C反应蛋白、铁蛋白及凝血面板显著改变。

临床怎么用

  • 对COVID-19门诊患者需警惕入院时即存在血栓形成,尤其静脉血栓栓塞。
  • 炎症标志物显著升高者可能需关注免疫血栓形成风险。

局限性

  • 单中心回顾性分析,样本量及混杂因素控制未在摘要中报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In the present study, we sought to better characterize the patients with coronavirus disease 2019 (COVID-19) most at risk of severe, outpatient thrombosis by defining the patients hospitalized with COVID-19 with arterial or venous thrombosis diagnosed at admission. METHODS: We conducted a single-center, retrospective analysis of COVID-19 patients. We found a shift in the proportions of thrombosis subtypes from 2019 to 2020, with declines in ST-segment myocardial infarction (from 22.0% to 10.1% of thrombotic events) and stroke (from 48.6% to 37.2%) and an increase in venous thromboembolism (from 29.4% to 52.7%). The patients with COVID-19-associated thrombosis were younger (age, 58 years vs 64 years; P = .043) and were less frequently women (31.3% vs 43.9%; P = .16). However, no differences were found in the body mass index or major comorbidities between those with and without COVID-19. COVID-19-associated thrombosis correlated with greater mortality (15.2% vs 4.3%; P = .016). The biometric profile of patients admitted with COVID-19-associated thrombosis compared with regular thrombosis showed significant changes in the complete blood count, liver function test results, D-dimer levels, C-reactive protein, ferritin, and coagulation panels. CONCLUSIONS: Outpatients with COVID-19 who developed thrombosis requiring hospitalization had increased mortality compared with outpatients without COVID-19 who developed thrombosis requiring hospitalization. Given the significantly higher inflammatory marker levels, it is possible this is related to different mechanisms of thrombotic disease in these patients. The inflammation could be a therapeutic target to reduce the risk, or aid in the treatment, of thrombosis. We call for more studies elucidating the role that immunothrombosis might be playing in patients with COVID-19.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Brosnahan SB, Smilowitz NR, Amoroso NE, et al. Thrombosis at hospital presentation in patients with and without coronavirus disease 2019. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 33186750. doi:10.1016/j.jvsv.2020.11.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。